Health Care Activity – Page 5

Merck Reports Strong Q3 Results but Lowers Full-Year Sales Guidance

6 months ago talkbio0Tagged Advice, Capvaxive, full-year, Gardasil, Januvia, Keytruda, Merck, results, Sales - occupational activity, Winrevair

Merck, Q3 Results, Full-Year Sales Guidance, Keytruda, Gardasil, Januvia, Winrevair, Capvaxive

Mitigating Risks in mRNA Manufacturing: Strategies for Smooth Transition from Preclinical to Clinical Stages

6 months ago talkbio0Tagged analytical method, Automation, bony process, clinical transition, Control Groups, Materials, Preclinical, Quality, regulatory, Risk Management, RNA, Messenger

mRNA manufacturing, risk management, preclinical to clinical transition, quality control, regulatory compliance, raw material selection, process automation, analytical methods.

Amazon One Medical Introduces AI Tools to Enhance Primary Care Experience

6 months ago talkbio0Tagged Amazona, Aortic Valve Insufficiency, generative, Healthcare technology, patient care, Primary Health Care, Workload

Amazon One Medical, AI tools, primary care, healthcare technology, generative AI, patient care, administrative workload

Noom and Waltz Health Collaborate on Affordable GLP-1 Weight Loss Program

6 months ago talkbio0Tagged Glucagon-Like Peptide 1, Health, Medication Management, Noom, Obesity

Noom, Waltz Health, GLP-1, weight loss, affordable, medication management, obesity treatment

Revolutionizing Talent Acquisition: The Future Impact of AI

6 months ago talkbio0Tagged AI-powered, Aortic Valve Insufficiency, Challenge, Efficiency, ethical, Future, personalization, Recruitment, Talent Acquisition

AI in Talent Acquisition, Future of Recruitment, AI-Powered Recruiting Tools, Efficiency and Personalization, Challenges and Ethical Considerations

Zealand’s Hypoglycemia Drug Faces Second FDA Rejection Due to Manufacturing Issues

7 months ago talkbio0Tagged CDMO, Congenital MeSH qualifier, dasiglucagon, Hyperinsulinism, Hypoglycemia, Inspection (procedure), Rejection (Psychology), United States Food and Drug Administration, Zealand Pharma

Zealand Pharma, FDA rejection, dasiglucagon, congenital hyperinsulinism, hypoglycemia, CDMO inspection

Mendaera Secures $73M Series B Funding to Revolutionize Mainstream Medical Procedures with Robotics and AI

7 months ago talkbio0Tagged Artificial Intelligence, Healthcare technology, Medical procedure, Mendaera, Robotics, Series B, Threshold, Ventures

Mendaera, Series B funding, robotics, AI, medical procedures, healthcare technology, Threshold Ventures

Senators Wyden and Brown Call for FTC Investigation into PBM “Co-Manufacturing” Practices

7 months ago talkbio0Tagged Benefit, Co-Manufacturing, competition, Drug Costs, Evaluation, Healthcare Industry, manager, Pharmaceutical Services, Pharmacy Benefit Manager, United States Federal Trade Commission

PBM reforms, FTC investigation, co-manufacturing, pharmacy benefit managers, drug costs, competition, healthcare industry

Senators Wyden and Brown Urge FTC to Expand Investigation into PBMs’ Anti-Competitive Practices

7 months ago talkbio0Tagged Agreement, Anti-Competitive, Benefit Managers, Co-Manufacturing, Evaluation, Health Care Reform, PBMs, Pharmaceutical Services, Prices, United States Federal Trade Commission

Pharmacy Benefit Managers (PBMs), Anti-Competitive Practices, FTC Investigation, Co-Manufacturing Agreements, Drug Prices, Healthcare Reform

Novo Nordisk CEO Faces Senate Scrutiny Over High Prices of Ozempic and Wegovy

7 months ago talkbio0Tagged Benefit Managers, coverage - financial contract, Health Care Systems, Hearing, Insurance, Nordisk, PBMs, Pharmaceutical Services, Prices, Senate, Wegovy

Novo Nordisk, Senate Hearing, Ozempic, Wegovy, Drug Prices, Pharmacy Benefit Managers (PBMs), Insurance Coverage, Healthcare System